Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Literature
1.
2.
3.
Womack CJ, Saunders MJ, Bechtel MK, Bolton DJ, Martin M, Luden ND, Dunham W, Hancock M (2012) The influence of a CYP1A2 polymorphism on the ergogenic effects of caffeine. J Int Soc Sports Nutr 9(1):7CrossRefPubMedCentralPubMed
4.
Pataky MW, Womack CJ, Saunders MJ, Goffe JL, D'lugos AC, El-Sohemy A, Luden ND (2016) Caffeine and 3-km cycling performance: effects of mouth rinsing, genotype, and time of day. Scand J Med Sci Sports 26(6):613–619CrossRefPubMed
5.
Pickering C, Kiely J (2018) Are the current guidelines on caffeine use in sport optimal for everyone? Inter-individual variation in caffeine ergogenicity, and a move towards personalised sports nutrition. Sports Med 48(1):7–16CrossRefPubMed
6.
Sachse C, Brockmöller J, Bauer S, Roots I (1999) Functional significance of a C→ a polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47(4):445–449CrossRefPubMedCentralPubMed
Metadata
Title
Caffeine, CYP1A2 genotype, and sports performance: is timing important?
Author
Craig Pickering
Publication date
01-02-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1811-4

Other articles of this Issue 1/2019

Irish Journal of Medical Science (1971 -) 1/2019 Go to the issue

Original Article

Microvascular diabetes complications in a specialist young adult diabetes service

Original Article

Variations in biochemical values for common laboratory tests: a comparison among multi-ethnic Israeli women cohort

Original Article

Coloproctology procedure clinic: a novel service developed to reduce suffering of patients with bleeding per rectum

Original Article

Acute hospital reconfiguration and self-harm presentations: a before-and-after study

Original Article

Attitudes of Irish patients with chronic pain towards medicinal cannabis

Original Article

Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits